GOLDSTEIN DOV A MD - 25 Feb 2025 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Director
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
25 Feb 2025
Net transactions value
$0
Form type
4
Filing time
25 Feb 2025, 21:30:05 UTC
Previous filing
20 Feb 2025
Next filing
25 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +5,000 $0.000000 5,000 25 Feb 2025 Common Stock, par value $0.0001 per share 5,000 $5.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.